Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis

Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis

Abstract Introduction Treatment guidelines recommend low-dose corticosteroids as short-term therapy among rheumatoid arthritis (RA) patients. However, it may be difficult to wean/eliminate steroids once initiated. Initiation of more effective therapies such as biologics may help to taper corticoster...

Full description

Bibliographic Details
Main Authors: Christina A. Spivey, Kevin L. Winthrop, Jenny Griffith, Cameron M. Kaplan, Yanru Qiao, Arnold E. Postlethwaite, Junling Wang
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-11-01
Series:Rheumatology and Therapy
Subjects:
Adalimumab
Corticosteroids
Medical costs
Rheumatoid arthritis
Online Access:http://link.springer.com/article/10.1007/s40744-019-00184-5

Internet

http://link.springer.com/article/10.1007/s40744-019-00184-5

Similar Items